The COPE LBP trial: Cognitive Patient Education for Low Back Pain - a cluster randomized controlled trial in primary care by Werner, Erik L et al.
STUDY PROTOCOL Open Access
The COPE LBP trial: Cognitive Patient Education
for Low Back Pain - a cluster randomized







Background: Non-specific low back pain (LBP) is usually self-limiting within 4-6 weeks. Longstanding pain and
disability are not predictable from clinical signs or pathoanatomical findings. Pain cognition and physical
performance have been shown to improve patients with chronic LBP following neurophysiological education. The
primary aim of this study is to evaluate whether a specific cognitive based education programme for patients with
LBP in primary care is more effective than normal care in terms of increased function. The secondary aims of the
study are to evaluate whether this intervention also results in earlier return to work, decreased pain, increased
patient satisfaction, increased quality-of-life, and cost utility.
Methods/Design: Cluster randomised controlled trial with 20 general practitioners and 20 physiotherapists in
primary care as the unit of randomisation. Each practitioner will recruit up to 10 patients, aged 20 to 55 years, with
non-specific sub-acute/chronic LBP of more than four weeks but less than 1 year’s duration. Practitioners in the
intervention arm will provide cognitive patient education intervention in up to four weekly sessions, each lasting
30 minutes. Practitioners in the control arm will provide normal treatment, but have to make four appointments
for the patients. Patients, outcome assessors, and study statistician will be blinded to group allocation.
Discussion: We present the rationale and design of an ongoing RCT study that potentially offers an easily
implemented treatment strategy for LBP patients in primary care. The results will be available in 2012.
Trial registration: ISRCTN04323845
Background
LBP is a major health problem in the society. The life-
time prevalence of LBP is estimated to 70% [1], the one-
year prevalence in Norway 53% [2] and two weeks pre-
valence 42% [3]. The direct and indirect annual cost in
Norway due to LBP is estimated to 15 Billion NOK, and
16% of long-term sickness absence and 16% of new dis-
ability claims have LBP as a primary diagnosis [4]. LBP
patients are also heavy health care consumers constitut-
ing 5-10% of all family doctors’ consultations [5,6], 27%
of the physiotherapists’ treatment and 82% of the chiro-
practors’ treatment [5,6].
As most acute LBP is self-limiting within few weeks
[1], only 10% of the patients are referred from their
family doctor to specialized health care [4]. However,
about 15% of acute LBP proceed to a chronic stage
(duration > 3 months), and 73% will have one or several
recurrences within a year [7]. An interesting feature of
LBP disability is that 75% or more of the costs of LBP
can be attributed to 5% of the patients. The decisive fac-
tors for future disability do not appear to be any charac-
teristics of the LBP; but are primarily psychosocial
factors [8].
Frustration arises because of the lack of consistency
among the professionals regarding treatment and under-
standing of the problem [9,10]. Unfortunately, the Nor-
wegian guidelines do not seem to have had great impact
on the health care providers’ practices [11,12]. Specific
strategies for implementing guidelines in primary care
have not shown changes in patients’ sickness behaviour
either [13,14].
The view on non-specific LBP has changed during the
past two decades from a purely “injury model” to a
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[15,16]. In this model, the back pain arises from noci-
ception of pain in the back caused by reasons or tissue
injury that cannot be identified. The pain may result in
varying degrees of dysfunction, not necessarily only
related to the magnitude of the injury, but also to how
the pain is perceived. The second element of this model
is how the patients think and feel about the dysfunction,
thus determining how it affects them. This involves
beliefs and coping strategies. The degree of anticipation,
anxiety, attention, and previous experiences reflect our
perception of the pain, leading in turn to beliefs that
determine how we manage to cope with the actual pain.
Based on this understanding, both international and
Norwegian guidelines recommend cognitive intervention
as an essential element in the treatment of long-lasting
LBP [1]. A recent systematic review on patient education
programmes for chronic LBP (such as back schools, brief
education, and fear-avoidance training) also recommended
brief education programmes in clinical settings [17].
We thus have sufficient knowledge about management
of LBP, which should theoretically reduce the conse-
quences of back pain to a minimum, but so far different
strategies for implementation of this knowledge have
failed to produce the desired results [18]. There is lim-
ited knowledge on effective ways to change clinical prac-
tice. In a recent systematic review of 235 studies on
guideline dissemination and implementation strategies,
the authors found more evidence for clinician-oriented
interventions (e.g. use of education, reminders, feedback)
than for intervention aimed at the organisation or the
patient [19]. Further, they found very little information
on patients’ outcomes or financial assessment of the
implementation strategies.
A mass media campaign has previously been con-
ducted in Norway, which aimed at changing public
beliefs and following health behaviour in back pain
patients [20]. Unlike an Australian campaign [21], but in
line with campaigns in Scotland and Canada [22,23], the
Norwegian campaign did not succeed in changing sick-
ness behaviour in terms of sick leave, surgery or the use
of imaging scans in patients with LBP.
Other previous randomised controlled trials designed
to implement LBP guidelines (and change the behaviour
of clinicians) have used different intervention including
educational outreach, multi-faceted intervention with
workshops and printed educational material, dissemina-
tion, and audit and feedback [24,25]. The effectiveness
of these trials varied with regard to the success of chan-
ging the behaviour of the clinicians [26]. However, these
studies did not include measurement of patient out-
comes or cost-effectiveness analysis.
One of the key messages in clinical guidelines for LBP
is the advice to remain active in order to prevent a
chronification of the LBP problem. However, there is lit-
tle theoretical basis for this advice. In this trial we want
to implement a cognitive based education programme,
which is theoretically based on current understanding
and knowledge of pain mechanisms. The primary aim of
t h i ss t u d yi st oe v a l u a t ew h e t h e ras p e c i f i cc o g n i t i v e
based education programme for patients with low back
pain in primary care is more effective than normal care
in terms of increased function. The secondary aims are
to evaluate whether this intervention also results in ear-
lier return to work, decreased pain, increased patient
satisfaction, increased quality-of-life, and cost utility.
Our main hypothesis is that this cognitive intervention
will result in higher physical function compared with
normal care. We also hypothesise that cognitive inter-
vention results in decreased pain, more satisfied




This study is a stratified cluster randomised controlled
trial taking place in primary care with family doctors
(GP) and physiotherapists (PT) in Oslo and Akershus
County in Norway. The design contains two arms in
which 20 GPs and 20 PTs will be stratified into, and
then randomised to either the intervention or the con-
trol provider group. Each cluster will contain the GPs/
PTs and their included patients.
Recruitment of practitioners
An invitation to an information meeting regarding the
project was sent out to all GPs and PTs working in the
primary health care in Oslo and Akershus County in
Norway in March 2008. After an information meeting,
the practitioners were invited to participate in the study.
A total of 20 GPs and 20 PTs were included and
randomised.
Strategies to promote participation of practitioners
into the trial included offering professional development
points and financial compensation for the extra time
spent on recruiting patients to the project, as well as
treatment of included patients.
Recruitment of patients and eligibility criteria
Each participating GP and PT in both intervention and
control groups will consecutively ask eligible patients to
participate in the study. The study is thus taking place
in a normal clinical setting. The inclusion criteria are:
￿ Men and women aged 20 - 55
￿ Unspecific LBP
￿ Duration from 4 weeks up to 1 year since onset of
actual pain episode
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￿ As c o r e≥ 4 on the Roland Morris Disability
Questionnaire
The following criteria excluded patients from partici-
pation:
￿ Provider’s uncertainty of diagnosis; possible nerve
root pain or severe pathology
￿ Signs of any ‘red flags’
￿ Particular interest in or demand for a specific
treatment
Consequently, all patients visiting his or her provider
because of back pain will be assessed according to these
inclusion and exclusion criteria. If the patient is found
eligible, he or she will be asked to participate. Those
who agree to participate will sign a consent form and
receive the questionnaires described later. The patients
may either answer the questionnaires immediately in the
provider’s waiting room, or at home. In both cases the
forms will be sent in a stamped and addressed envelope
before the first session of the trial. The provider will
inform the study management by an enrolment fax and
arrange for the first session within a week of inclusion.
Those who do not want to participate in the study or
fail to satisfy the criteria will be registered by initials,
year of birth, score on the Roland Morris Disability
Questionnaire and the reason for not participating. All
the procedures are identical for both intervention and
control groups.
Randomisation and allocation procedure
GPs and PTs were randomly allocated to either the
intervention or control group. A block randomisation
procedure with stratification for type of health care pro-
vider (GP and PT) was carried out to ensure a similar
number of participants in the four blocks (GP and PT
intervention, GP and PT control). The randomisation
procedure was carried out by computer-generated num-
bers that were placed in closed non-transparent envel-
opes. An independent person administrated this
procedure. Patients and outcome assessors will be
blinded regarding group allocation.
Intervention group
The professionals have been trained in the specific
model of LBP treatment based on the biopsychosocial
understanding of LBP and the “intensive neurophysiol-
ogy education”. Following this training they will provide
their LBP patients in their normal clinical settings with
a four-session treatment programme consisting of this
education programme in addition to their normal treat-
ment. At each treatment session the caregiver will stick
to the procedures described in detail in the trial manual
when communicating with the patient.
The “intensive neurophysiology education” programme
has been developed by a group of British and Australian
researchers as an education programme for patients
with LBP. The cognitive elements of this programme
consist basically of an understanding of pain that differs
somewhat from the traditional “injury model”. This the-
ory is primarily based on the neurophysiology of pain,
reflected by sensitisation and neuronal response to inac-
tivity and movement control [27]. Based on this, the
education programme has three basic elements [28]:
￿ Reduction of what the patients perceive as threa-
tening inputs to the brain
￿ Targeting the patients’ own understanding of the
pain
￿ Exposure to the threatening inputs
Previous studies have documented an additional effect
of “intensive neurophysiology education” when com-
bined with physiotherapy [27].
The intervention will be given as four 30-minute ses-
sions once a week for four consecutive weeks. This
treatment is specified in a manual for this trial and all
intervention doctors and physiotherapists have attended
the 18 lessons course. They are also provided with a
written summary of the content of each session.
Each of the sessions has a specific content of educa-
tion and discussion in the one-to-one setting between
the provider and the patient. Initially the discussion
concerns the thoughts and fears of the patients and
their LBP. Eventually, the education programme will
deal more and more with exposure to movements and
daily activities that the patients more or less deliberately
avoid because of fear of provoking pain. As homework
between the sessions, the patients will be asked to iden-
tify barriers to normal functioning, reasons for fear
avoidance behaviour and other reflections related to the
education. They will also be asked to make specific
registrations regarding function, pain and work absence.
Control group
The providers of the control group are asked to register
and include all patients meeting the inclusion criteria in
a similar manner. These patients will also answer on all
questionnaires, and will meet their provider weekly for
up to four weeks. These sessions have no defined con-
tent, but the providers will spend somewhat more time
on these patients than the regular schedule, asking for
more details on what prevents them from resuming nor-
mal activity. The control group providers have not parti-
cipated in the training course of the intervention and
therefore their care will consist of whatever is the
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siotherapist, only that the time spent for each patient
will be somewhat longer than normal (particularly for
the doctors). This is done to minimise the effect of the
increased attention in itself so that any observed differ-
ences between the groups are more likely to be due to
the “intensive neurophysiology education”.
Data collection
Patients will initially be asked by the provider to
answer the questionnaires in the waiting room imme-
diately after signed consent. At baseline the patients
will fill in a registration form and a baseline question-
naire regarding sociodemographics (age, gender, mari-
tal status, education, and work status), other diseases,
use of medicines, a standardised screening question-
naire on psychosocial risk factors - the Örebro Muscu-
loskeletal Pain Questionnaire [29,30] and the baseline
measures of the outcomes. In addition, three standar-
dised questionnaires assessing beliefs about pain, the
Pain Catastrophizing Scale [31], the brief version of
the Illness Perception Questionnaire [32,33], and
beliefs about LBP [20] will be included. The two first
questionnaires will be translated into Norwegian and
tested for psychometric properties before start of the
main study.
During the first four weeks, all the patients will fill in
a weekly report regarding work status and pain rating.
The patients will be contacted again after 4-5 weeks,
and after 3, 6, and 12 months after inclusion. At 4-5
weeks, 3 and 6 months, the patients will be contacted
by telephone for the registration of work status and pain
rating, and at 4-5 weeks and 12 months follow-up the
patients will also fill in a postal comprehensive question-
naire including outcome measures and questions about
possible co-intervention.
Outcome measures
Outcome measures will be recorded by an assessor
blinded to group allocation. The primary outcome is
function (disability) assessed by the Roland Morris Dis-
ability Questionnaire (RMQ) [34-36], a self-administered
questionnaire with score 0-24, with 0 corresponding to
no disability. The RMQ is a frequently used outcome
measure in trials related to LBP.
The secondary outcomes are as follows:
￿ Pain; measured on a numerical rating scale from 0
to 10
￿ Return to work; reported as number of days from
first visit to the health care provider until complete
or partial return to work - and as a total number
of days absent from work the following year
￿ Overall satisfaction; measured on a numerical rat-
ing scale from 0 to 10
￿ Health related quality of life; assessed by the Euro-
QoL-5D [37] and Patient-Generated Index (PGI)
[38]
￿ A cost-effectiveness analysis will be carried out by
using both the return-to work outcome and the
EuroQoL 5D, and by estimating the total cost of
all the four groups of doctors and physiotherapists
in this trial.
Compliance
In order to assess compliance with the treatment inter-
vention, three initiatives are taken: Firstly, the interven-
tion clinicians filled in a knowledge test before and after
the 2-day seminar with Lorimer Moseley. This test has
been developed by David Butler and Lorimer Moseley,
and is frequently used when providing the “explain
pain” courses. The test will be used again in one of the
follow-up meetings throughout the project period.
Secondly, in order to evaluate the clinician’sp e r c e p -
tion of the intervention he/she has provided, the clini-
cians reply to some questions regarding the content of
the provided intervention for each of the patients
included.
Thirdly, in order to evaluate the patient’s perception
of the intervention he/she has received, a telephone
interview after the last treatment session is carried out.
All included patients (regardless of group allocation) are
asked identical questions.
Data analysis
A daily checking for accuracy and completion of data
forms and double data entry will be used to ensure
quality of the data. Data will be analysed by a statistician
w h oi sb l i n d e dt og r o u ps t a t us. The primary analyses
will be by intention-to-treat and we will restrict the
number of analyses in order to reduce the possibility of
Type I errors. For primary outcomes, a p value of < 0.05
will be considered statistically significant. For the sec-
ondary outcomes a p value of < 0.01 will be considered
statistically significant.
Differences between the groups will be presented as a
mean with 95% CI or in categories with odds ratio for
categorical data. For the primary outcome of days to
return to work a survival curves analysis with a log-rank
statistic will be used to assess differences between the
groups, and Cox’s regression to assess the effects of
treatment (group) status on hazard rates for time to
return to work. A mixed model with group as a fixed
factor will be used for the other outcome measures. If
there is a significant difference between treatment
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also test for potential confounding factors in these mod-
els. Analyses of prognostic factors will be carried out by
multivariate regression models.
Sample size
The primary outcome of the study is patient-reported
function as measured on a continuous measure (Roland-
Morris Questionnaire). Based on previous Norwegian
studies using the RMQ for patients with LBP, a clinically
relevant difference between two groups can be estimated
to be approximately 2 points with a SD of 3. This is also
similar to a previous evaluation study of the “intensive
neurophysiology education” carried out by Moseley et al
[27]. We put the significance level (alpha) to 5% with
the probability of at least 80% to discover a difference
between the two intervention groups. If the difference
between mean changes in the two groups is at least 10%
(approximately 2-3 points) with SD of 3, we will need
approximately 50 patients in each group. Adjusting for
the cluster design of 20 different clusters and loss to fol-
low-up we end up with 150 patients in each group, total
n = 300 patients, that is 75 patients in each block. It
seems from this sufficient if each provider recruits 7 or
8 patients each in order to obtain 300 in total.
Discussion
We present the rationale and design for an RCT exam-
ining the effects of a specific cognitive based education
model for management of sub-acute LBP in normal pri-
mary care settings. The primary outcome will be disabil-
ity as measured by Roland-Morris Disability
Questionnaire. The secondary outcomes include pain,
return to work, patient satisfaction, quality-of-life, and
cost utility. Data collection will take place at inclusion,
at the end of the four-week treatment programme and
at 12 months. The study period will go through 2009
and 2010 and the results will be available in 2012.
If the study succeeds in demonstrating a significant
positive effect on any of the outcome measures, the
potential gain is huge, not only for the LBP patients, but
also for the societal costs and for the health care, because
of the large number of patients and their disability.
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